LH Labcorp Holdings Inc.
Healthcare$258.45-0.57%ClosedMarket Cap: $21.19B
As of 2026-05-26
Valuation
P/E (TTM)
24.68
PEG
1.41
P/B
2.45
P/S
1.51
EV/EBITDA
13.29
DCF Value
$380.02
FCF Yield
6.5%
Div Yield
1.1%
Margins & Returns
Gross Margin
27.8%
Operating Margin
11.0%
Net Margin
6.7%
ROE
10.9%
ROA
4.9%
ROIC
7.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $3.54B | 26.5% | $387.2M | $277.8M | $— | $0.72 |
| Q4 null | $3.52B | 26.2% | $382.0M | $164.7M | $— | $0.72 |
| FY null | $13.95B | 26.8% | $1.52B | $876.5M | $— | $2.88 |
| Q3 null | $3.56B | 28.8% | $396.6M | $261.1M | $— | $0.72 |
| Q2 null | $3.53B | 29.7% | $394.5M | $237.9M | $— | $0.72 |
| Q1 null | $3.35B | 28.3% | $326.0M | $212.8M | $— | $0.72 |
| Q4 null | $3.33B | 26.9% | $216.5M | $143.4M | $— | $0.72 |
| FY null | $13.01B | 27.9% | $1.09B | $746.0M | $— | $2.88 |
| Q3 null | $3.28B | 27.6% | $254.1M | $169.3M | $— | $0.72 |
| Q2 null | $3.22B | 28.8% | $294.8M | $205.3M | $— | $0.72 |
| Q1 null | $3.18B | 28.2% | $321.3M | $228.0M | $— | $0.72 |
| Q4 2023 | $3.03B | 27.1% | $-122.8M | $-167.1M | $-1.97 | $0.72 |